In particular, the unfavorable outcome of neuroblastoma is associated with deletion of chromosomes 1p or 11q, gain of chromosome 17q, or amplification of the MYCN proto-oncogene [32,33]. The gene discussed is MYCN; the disease is neuroblastoma.